PMN
PMN
NASDAQ · Biotechnology

Promis Neurosciences Inc

Biotech Stocks Healthcare Stocks
$12.73
-0.37 (-2.82%)
As of Feb 8, 2:23 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +80.7% upside
Low Target $15.62
Average Target $23.00
High Target $28.09
Current Price $12.73
Current
$12.73
Target
$23.00
$15.62 $23.00 avg $28.09
Scenario Analysis
Bear Case
$15.62
22.7%
Low target
Base Case
$23.00
+80.7%
Avg target
Bull Case
$28.09
+120.7%
High target
Risk/Reward
5.3x
Highly favorable
Price in Context
52-Week High
$17.92
-29.0% from high
52-Week Low
$9.41
+35.3% from low
Target vs 52W High
$23.00
+28.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%